RCMT Q3 2025: Engineering Backlog Surges 233%, Anchoring Multi-Year Growth Visibility
RCM Technologies exits Q3 with a record $70 million engineering backlog for 2026, up sharply from $21 million the year prior, locking in multi-year visibility and reinforcing its positioning as a tier one utility and infrastructure partner. While healthcare and aerospace delivered robust growth, persistent excess medical costs and uneven cash flow highlight ongoing cost and operational headwinds. The company’s strategic bets on foreign nurse recruitment, AI-driven compliance, and grid modernization are set to shape its 2026 trajectory as capital allocation remains disciplined and focused on core strengths.
Summary
- Engineering Backlog Expansion: Record $70 million backlog secures visibility and leverages utility demand tailwinds.
- Healthcare Penetration Deepens: Share gains in K-12 and foreign nurse pipeline investment underpin future growth.
- Operational Discipline Remains: Capital allocation stays flexible as cost inflation and working capital volatility persist.
Business Overview
RCM Technologies provides specialized staffing, consulting, and engineering services through three primary segments: Healthcare (K-12 school and hospital staffing), Engineering (energy, infrastructure, aerospace, and industrial process), and Life Sciences/Data Solutions (compliance, automation, analytics). Revenue is generated via project-based and recurring client contracts, with a focus on deep penetration of existing accounts and select expansion into new verticals. The company’s model leverages domain expertise, global talent pipelines, and digital innovation to differentiate in highly regulated and technical markets.
Performance Analysis
RCMT delivered resilient Q3 results despite cost headwinds, led by standout growth in engineering and healthcare segments. Engineering gross profit reached a record high, supported by surging demand for utility grid modernization and data center interconnect projects. The healthcare group grew school revenue by over 20% year-over-year, expanding its roster of partner schools and deepening share in core K-12 markets, even as non-school revenue declined and summer session activity proved unpredictable.
Persistent excess medical costs—$1.8 million year-to-date—pressured margins, particularly in healthcare, and contributed to a slight decline in consolidated adjusted EBITDA. Operational cash flow was constrained by delayed collections from large school clients, though management expects normalization in Q4. The Life Sciences/Data Solutions segment saw a modest dip in gross profit, but margin improvement was supported by AI-driven compliance and analytics initiatives. Overall, segment performance highlights strong execution in core verticals, offset by ongoing cost and working capital challenges.
- Engineering Outperformance: Gross profit up 17% year-over-year, with backlog for 2026 more than tripling, anchoring future growth.
- Healthcare Growth and Volatility: School revenue expanded 20%, but non-school revenue fell and summer session volumes were below expectations.
- Cost Inflation Drag: Medical claims and insurance cost inflation remain a material drag on overall profitability.
The company’s focus on high-value clients and operational flexibility has allowed it to outperform peers, but further cost discipline and cash flow improvement will be critical to sustain momentum into 2026.
Executive Commentary
"As we exit our seasonal third quarter, we are entering Q4 from a position of strength, demonstrating record 2026 engineering backlog as of the end of October and continued momentum in healthcare. Penetration of existing clients continues to increase, while commercial discussions start to crystallize with future flagship clients."
Brad Veazey, Executive Chairman
"We reiterate that we expect Q4 to yield our highest quarterly gross profit and our highest adjusted EBITDA in fiscal 2025. We believe we have strong momentum heading into 2026."
Kevin Miller, Chief Financial Officer
Strategic Positioning
1. Engineering: Utility Grid and Data Center Tailwinds
RCMT’s engineering segment is capitalizing on the surge in utility CapEx and data center grid interconnects, focusing on tier one utility clients and complex, multidisciplinary projects. The record $70 million backlog for 2026 reflects both long-cycle demand and successful positioning as a preferred partner for grid modernization. The company’s integrated EPC (engineering, procurement, construction) model and hybrid resourcing—combining domestic and global expertise—enable it to scale for large projects and mitigate labor shortages, a key differentiator in the current environment.
2. Healthcare: K-12 Penetration and Foreign Talent Pipeline
Healthcare continues to deliver robust growth in its core K-12 staffing business, expanding both client count and wallet share despite increased competition. RCMT’s sustained investment in foreign nurse recruitment, with a pipeline of 300+ candidates, positions the segment for future hospital expansion once visa constraints ease. The company’s expertise in international recruiting is a structural advantage over peers who have scaled back, setting up a potential supply-led acceleration in 2026.
3. Life Sciences and Data Solutions: AI and Compliance Differentiation
RCMT is leveraging AI-driven compliance and analytics partnerships to streamline protocols and unlock new value for life sciences clients. The formation of a dedicated life sciences engineering group and expansion of managed service offerings are intended to capture growth from industry digitalization and regulatory complexity. Early traction in predictive analytics and real-time monitoring supports the company’s ambition to be a strategic partner in process automation and innovation.
4. Capital Allocation: Disciplined Flexibility
With 45% of outstanding shares repurchased over recent years, management has signaled a preference for buybacks over dividends, maintaining balance sheet flexibility to support opportunistic investments and deleveraging. The company’s insider ownership and focus on maintaining a healthy float reflect a nuanced approach to capital structure, while the revolver provides optionality for future growth initiatives.
5. Operational Agility: Talent and Digital Presence
Investments in brand awareness and digital recruiting have elevated RCMT’s visibility, attracting higher-caliber talent and enabling the company to bolt on new capabilities quickly. This operational agility, combined with a strong reputation in core markets, supports both organic growth and selective expansion into adjacencies such as substitute teaching and BPO (business process outsourcing) in the Philippines.
Key Considerations
RCMT’s Q3 results reflect a business executing well in its core segments, with strategic investments and operational discipline positioning it for multi-year growth—yet cost inflation and cash flow volatility remain watchpoints.
Key Considerations:
- Engineering Backlog Anchors 2026 Visibility: The tripling of engineering backlog is a clear signal of demand durability and competitive positioning in utility and infrastructure markets.
- Healthcare Foreign Recruitment Pipeline: Heavy investment in foreign nurse sourcing could unlock significant growth if visa retrogression eases, giving RCMT a structural supply advantage.
- Persistent Cost Headwinds: Excess medical claims and insurance inflation are weighing on margins, with mitigation measures unlikely to yield relief until 2026.
- Cash Flow Execution: Administrative delays in client collections highlight ongoing working capital management challenges, with Q4 expected to see improvement.
- Capital Allocation Optionality: Management’s disciplined approach to buybacks and debt provides room to maneuver as market opportunities arise.
Risks
Cost inflation in medical claims and insurance, if persistent, could continue to compress margins and limit reinvestment capacity. Visa retrogression remains an uncontrollable gating factor for foreign nurse deployment in healthcare. Cash flow volatility, driven by client payment cycles, could impact liquidity and limit capital allocation flexibility. Finally, competitive intensity in K-12 and engineering markets requires ongoing investment to maintain share and differentiation.
Forward Outlook
For Q4 2025, RCMT guided to:
- Highest quarterly gross profit of the year
- Record adjusted EBITDA for fiscal 2025
For full-year 2025, management expects:
- Strong finish, with momentum carrying into 2026 based on backlog and healthcare pipeline
Management highlighted several factors that will shape the outlook:
- Continued investment in engineering capacity and digital innovation
- Monitoring visa and regulatory developments for healthcare hiring
Takeaways
RCMT’s Q3 results confirm the company’s ability to capture multi-year growth in engineering and healthcare, while disciplined capital allocation and operational agility support its long-term positioning.
- Engineering Anchors Future Growth: Record backlog and preferred partner status in utilities lock in visibility and pricing power.
- Healthcare Diversification: K-12 core remains robust, with hospital expansion poised to accelerate if foreign nurse pipeline can be unlocked.
- Watch Cost and Cash Flow: Investors should monitor the company’s ability to contain medical inflation and improve working capital execution as scale increases.
Conclusion
RCMT exits Q3 2025 with a fortified backlog, strong healthcare momentum, and a disciplined approach to capital and operations. While cost inflation and collections remain challenges, the company’s strategic positioning and investment in talent and technology provide a credible path to sustained growth into 2026 and beyond.
Industry Read-Through
The surge in utility grid and data center infrastructure demand is a structural tailwind for engineering and EPC firms, with multi-year CapEx cycles providing rare visibility. Healthcare staffing remains highly competitive, but firms with global recruiting infrastructure are best positioned to capitalize as regulatory constraints ease. The integration of AI and digital compliance in life sciences is becoming table stakes, with early adopters gaining efficiency and client stickiness. Persistent cost inflation and working capital volatility are sector-wide risks, underscoring the need for operational discipline and flexible capital allocation across staffing and engineering services industries.